Arch Venture Fund VII LP

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Arch Venture Fund VII LP
CIK #0001402439
EDGAR Form CIK 2011 - 2026
3 [0001402439]
4 [0001402439]
SC 13D [0001402439]
SC 13G [0001402439]
Form 13D/13G Filer Form 13D/13G Subject Filed
Arch Venture Fund VII LP 908 Devices Inc [2021-02-04]
Arch Venture Fund VII LP Twist Bioscience Corp [2019-02-14]
Arch Venture Fund VII LP Unity Biotechnology Inc [2019-02-14]
Arch Venture Fund VII LP Phaserx Inc [2016-06-06]
Arch Venture Fund VII LP Pulmatrix Inc [2015-06-25]
Arch Venture Fund VII LP Sage Therapeutics Inc [2015-02-11]
Arch Venture Fund VII LP Juno Therapeutics Inc [2015-02-11]
Arch Venture Fund VII LP Bind Therapeutics Inc [2014-02-06]
Arch Venture Fund VII LP Agios Pharmaceuticals Inc [2014-02-06]
Arch Venture Fund VII LP Bluebird Bio Inc [2014-02-06]
View All
Form 3/4/5 Subject 2011 - 2026
Arch Venture Partners X LLC
Arch Venture Partners VIII LLC
Arch Venture Fund X Overage LP
Arch Venture Partners X LP
Neumora Therapeutics Inc
Arch Venture Fund X LP
Arch Venture Fund VII LP
Arch Venture Fund VIII Overage LP
Arch Venture Partners X Overage LP
Arch Venture Partners VII LP
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Neumora Therapeutics Inc NMRA
Common Stock
2025-10-27 Buy 1,915,700 $2.61 4,999,977
Neumora Therapeutics Inc NMRA
Common Stock
2023-12-08 Other 703,061
Neumora Therapeutics Inc NMRA
Common Stock
2023-12-08 Other 1,176,593
Neumora Therapeutics Inc NMRA
Series B Preferred Stock · derivative
2023-09-19 Conversion 2,124,143
Neumora Therapeutics Inc NMRA
Series A-1 Preferred Stock · derivative
2023-09-19 Conversion 684,167
Neumora Therapeutics Inc NMRA
Series A-1 Preferred Stock · derivative
2023-09-19 Conversion 1,144,973
Neumora Therapeutics Inc NMRA
Common Stock
2023-09-19 Conversion 6,895,021
Neumora Therapeutics Inc NMRA
Common Stock
2023-09-19 Conversion 1,144,973
Neumora Therapeutics Inc NMRA
Common Stock
2023-09-19 Conversion 684,167
Neumora Therapeutics Inc NMRA
Series A-2 Preferred Stock · derivative
2023-09-19 Conversion 6,576,400
Neumora Therapeutics Inc NMRA
Series A-2 Preferred Stock · derivative
2023-09-19 Conversion 6,895,021
Neumora Therapeutics Inc NMRA
Common Stock
2023-09-19 Buy 1,500,000 $17.00 25,500,000
Neumora Therapeutics Inc NMRA
Common Stock
2023-09-19 Conversion 2,124,143
Neumora Therapeutics Inc NMRA
Common Stock
2023-09-19 Conversion 6,576,400
908 Devices Inc MASS
Series D Preferred Stock · derivative
2020-12-22 Conversion 665,661 $0.00
908 Devices Inc MASS
Series E Preferred Stock · derivative
2020-12-22 Conversion 180,578 $0.00
908 Devices Inc MASS
Series B Preferred Stock · derivative
2020-12-22 Conversion 981,443 $0.00
908 Devices Inc MASS
Common Stock, par value $0.001
2020-12-22 Buy 300,000 $20.00 6,000,000
908 Devices Inc MASS
Common Stock, par value $0.001
2020-12-22 Conversion 5,425,045
908 Devices Inc MASS
Series A Preferred Stock · derivative
2020-12-22 Conversion 2,927,386 $0.00
showing 20 of 109 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com